Literature DB >> 26271415

Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma.

Hong Zhang1, Junyi Ye1, Xiaoling Weng1, Fatao Liu2, Lin He3, Daizhan Zhou4, Yun Liu5.   

Abstract

Hepatocellular carcinoma (HCC) is the most common type of liver cancer in the world. Portal vein tumor thrombus (PVTT) is one of the most serious complications of HCC and is strongly correlated with a poor prognosis for HCC patients. However, the detailed mechanism of PVTT development remains to be explored. In this study, we present a large-scale transcriptome analysis, by RNA sequencing, of 11 patients diagnosed with HCC with PVTT. The dysregulated genes between HCC and PVTT suggested that the extracellular matrix receptor interaction was correlated with the venous metastases of HCC. Among all of the recurrent alternative splicing events, we identified exon 6 skipping of RPS24, which is likely to be a cancer driver. We also identified five common fusion genes between HCC and its corresponding PVTT samples, including ARID1A-GPATCH3, MDM1-NUP107, PTGES3-RARG, PRLR-TERT, and C9orf3-TMC1. All of these findings broaden our knowledge of PVTT development and may also contribute to the diagnosis and treatment of HCC patients with PVTT.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; alternative splicing; differentially expressed genes; gene fusion; portal vein tumor thrombus

Mesh:

Substances:

Year:  2015        PMID: 26271415     DOI: 10.1016/j.cancergen.2015.06.002

Source DB:  PubMed          Journal:  Cancer Genet


  22 in total

1.  Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma.

Authors:  Guoqiao Chen; Xiaoxiao Fan; Yirun Li; Lifeng He; Shanjuan Wang; Yili Dai; Cui Bin; Daizhan Zhou; Hui Lin
Journal:  Epigenetics       Date:  2020-01-14       Impact factor: 4.528

2.  Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.

Authors:  Lu Zhang; Xiaoqiao Liu; Xuegong Zhang; Ronghua Chen
Journal:  Mol Genet Genomics       Date:  2015-12-28       Impact factor: 3.291

3.  Screening potential prognostic biomarkers for portal vein emboli in patients with hepatocellular carcinoma.

Authors:  Weijie Zhou; Da Lang Fang; Yongfei He
Journal:  J Gastrointest Oncol       Date:  2021-08

4.  Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq.

Authors:  Yanting Shen; Lu Bu; Rui Li; Zhenzhu Chen; Fei Tian; Na Lu; Qinyu Ge; Yunfei Bai; Zuhong Lu
Journal:  Oncotarget       Date:  2017-04-25

5.  Recurrently deregulated lncRNAs in hepatocellular carcinoma.

Authors:  Yang Yang; Lei Chen; Jin Gu; Hanshuo Zhang; Jiapei Yuan; Qiuyu Lian; Guishuai Lv; Siqi Wang; Yang Wu; Yu-Cheng T Yang; Dongfang Wang; Yang Liu; Jing Tang; Guijuan Luo; Yang Li; Long Hu; Xinbao Sun; Dong Wang; Mingzhou Guo; Qiaoran Xi; Jianzhong Xi; Hongyang Wang; Michael Q Zhang; Zhi John Lu
Journal:  Nat Commun       Date:  2017-02-13       Impact factor: 14.919

6.  LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method.

Authors:  Junwei Han; Siyao Liu; Zeguo Sun; Yunpeng Zhang; Fan Zhang; Chunlong Zhang; Desi Shang; Haixiu Yang; Fei Su; Yanjun Xu; Chunquan Li; Huan Ren; Xia Li
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

7.  CSF1R methylation is a key regulatory mechanism of tumor-associated macrophages in hepatocellular carcinoma.

Authors:  Bin Cui; Xiaoxiao Fan; Daizhan Zhou; Lifeng He; Yirun Li; Dandan Li; Hui Lin
Journal:  Oncol Lett       Date:  2020-06-11       Impact factor: 2.967

8.  Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis.

Authors:  Qi Pan; Xianli Long; Liting Song; Dachun Zhao; Xiaoyuan Li; Dewei Li; Min Li; Jiahua Zhou; Xia Tang; Hong Ren; Keyue Ding
Journal:  Oncotarget       Date:  2016-06-21

9.  Development Of A Three-Gene Prognostic Signature For Hepatitis B Virus Associated Hepatocellular Carcinoma Based On Integrated Transcriptomic Analysis.

Authors:  Yao Yang; Qian Lu; Xuejun Shao; Banghui Mo; Xuqiang Nie; Wei Liu; Xianhua Chen; Yuan Tang; Youcai Deng; Jun Yan
Journal:  J Cancer       Date:  2018-04-30       Impact factor: 4.207

10.  Methylation patterns of RASA3 associated with clinicopathological factors in hepatocellular carcinoma.

Authors:  Hui Lin; Xiaoxiao Fan; LiFeng He; Daizhan Zhou
Journal:  J Cancer       Date:  2018-05-25       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.